Date: 2012-12-21
Type of information: Production agreement
Compound: fully automated emulsion PCR instrument
Company: Roche (Switzerland) Precision System Science (Japan)
Therapeutic area:
Type agreement: development
manufacturing
production
Action mechanism:
Disease:
Details: Roche and Precision System Science have announced the signing of an exclusive agreement to develop and manufacture a fully automated emulsion PCR instrument for Roche\'s portfolio of next-generation sequencing platforms. It is intended to support Roche\'s GS Junior and GS FLX+ systems as well as the sequencing platforms that Roche is currently developing.
The new instrument will be designed to streamline the sample preparation workflow by automating the entire emulsion PCR process thereby reducing the total hands-on time from several hours to a few minutes.
Financial terms:
Latest news:
